Menopause Hormone Therapy
Provider evaluation · Appropriate testing · Ongoing monitoring
The Warning That Shaped Twenty Years Of Advice Was Removed
In November 2025 HHS and the FDA announced removal of the boxed warnings on menopausal hormone therapy, and the labeling change took effect in February 2026. The FDA approved changes to six menopausal hormone therapy products, deleting the risk statements on cardiovascular disease, breast cancer and probable dementia from the boxed warning. One warning remains: the boxed warning for endometrial cancer on systemic estrogen-alone products was not removed. That labeling shaped how a generation of women were advised. If you raised this with a doctor in 2008 and were told the risks ruled it out, the basis for that advice has since been revised. It does not mean hormone therapy is right for everyone. It means the conversation is worth having again. Roughly 1.3 million women in the United States enter menopause each year, and by most estimates fewer than 2% receive adequate treatment. At T Clinics USA in Naples, Fort Myers, and Coral Springs, that conversation happens in person, with a provider who has your history and your labs, in a practice that treats both men and women. Results vary by individual.
A Conversation Worth Reopening
Menopause hormone therapy at T Clinics USA is prescribed after an in-person evaluation at one of three Florida clinics.
How It Works






